Survival after yttrium‐90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation

By B. Sangro, L. Carpanese, R. Cianni, R. Golfieri, D. Gasparini, S. Ezziddin, P. Paprottka, F. Fiore, Mark Van Buskirk, Jose Ignacio Bilbao and 15 more. Hepatology, 2011

667 citations recorded by the source corpus.

Subfields: Hepatology, Surgery

View Paper: https://www.semanticscholar.org/paper/f6ed8b0701b6dd017c035093fc87758ea1097b1e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. X. Li
2. J. Balogh
3. H. Monsour
4. D. Victor
5. A. Saharia
6. R. Ghobrial
7. E. Asham
8. S. G. Burroughs

Citations in the corpus

• Hepatocellular carcinoma: a review (2016, background): “This procedure has been shown to be safe and effective in cirrhotic patients with HCC.(131,132) One major advantage of Y-90 over TACE is that it is indicated in the case of portal vein neoplastic thrombosis, while TACE traditionally has been considered a contraindication.”